I think FierceBiotech is keeping a running total. I didn't find it in a search of the site, but remember it from their e-mails. Next one I get I'll try and remember to look.
LONDON 02/05/09 - 11:12 AM EST -- British drugmaker GlaxoSmithKline (GSK Quote - Cramer on GSK - Stock Picks) said Thursday it would cut jobs and costs as fourth quarter net profit dropped 1% due to higher research and sales spending.
The company booked a net profit of 1.0 billion pounds ($1.46 billion), down slightly from 1.1 billion pounds in the fourth quarter of 2007. Sales increased to 6.91 billion pounds from 5.97 billion pounds a year earlier, but profits were hurt by higher costs for research and development and general administration and sales.
Glaxo said it would increase its restructuring efforts and will seek to cut costs by 1.7 billion pounds a year by 2011, up from the 0.7 billion targeted previously.
That will mean job cuts, although the company would not say how many would be necessary. It said it would announce a figure after holding talks with employees and unions.
Media reports have estimated as many as 10,000 layoffs, 10% of the company's work force.
Market Data 
Markets 
AI
